Emory Patent Group: Protecting Emory Inventors’ Intellectual Property Since 2010

It’s a tale as old as tech transfer: an academic researcher invents a revolutionary technology and wants to get it out of the lab to the public, maximizing its real-world impact. But there are many steps involved in this process – including securing intellectual property protection via patents. For that, they’ll need a patent application with strong claims and knowledge of their university’s IP policy. If they’re an Emory inventor, the Emory Patent Group (EPG) is the go-to resource for navigating the patent process. Patent Power When Emory inventors make a discovery or innovate a new technology, they disclose it Read More …

Marking Milestones: 40 Years of Firsts at Emory OTT

At Emory Office of Technology Transfer (OTT), we’ve trailblazed many “firsts” in our 40 years, which have opened the door to hundreds of discoveries, partnerships, and breakthroughs — events that continue to define our impact today. Here are 9 milestones worth remembering. First Invention Disclosure: A Potential Drug to Control Steroids In 1985, the same year OTT began, the first invention disclosure was submitted: “Novel Compounds for Inhibition of Steroid Biosynthesis” from inventor Dave Lambeth, PhD. An invention disclosure is the confidential document that starts the journey from idea to impact, capturing the details of a discovery so OTT can Read More …

15 Good Minutes: Lily Yang, MD, PhD

When asked to describe her job, Lily Yang, MD, PhD, said that she is first and foremost “a translational scientist of oncology research.” Yang is also a professor of Surgery and Radiology and Imaging Sciences, the Nancy Panoz Chair of Surgery in Cancer Research, and Director of the Surgical Oncology Nanomedicine Research Lab, all at the Emory University School of Medicine. She is an innovator and researcher within the field of oncology, and she has made a career of recognizing shortcomings in clinical management of cancer patients, filling the gaps in oncological knowledge, and developing better treatment options for cancer Read More …

No Patent Needed: Commercializing with Copyrights and Open-Source Licenses – Part 2

In Part 1 of this series, we learned how OTT helps inventors commercialize their copyrighted work while also exploring some of the limitations of copyrights, including the problems that can arise when inventors use copyleft licenses or reveal details of their inventions before securing their intellectual property. Below, we will learn about open-source software (OSS) licenses and how they factor into the commercialization process, or how they might impact commercialization. What is Open Source? When talking about software, open-source generally means that anyone can access and modify the software in question for free. When commercializing, there are two ways in Read More …

OTTie’s Summer Travels: Following Emory OTT’s favorite office mascot around the world

At Emory’s Office of Technology Transfer (OTT), we’ve long referred to ourselves as “OTT-ers”— pronounced like “otters,” the adorable marine mammal. While the nickname started off organically, it eventually stuck, becoming a fun, unofficial way to describe the team. That same nickname also inspired the introduction of OTTie: a plush, stuffed otter who got his start a few years ago as a way to celebrate the work happening within the office. But OTTie quickly became more than just a symbol of success—he’s become a member of the team in his own right. He’s posed for photos, been passed from desk Read More …

NAI Member Spotlight: A Q&A with faculty driving innovation at Emory OTT

Faculty research is what drives our work in Emory’s Office of Technology Transfer (OTT). Their discoveries shape every part of our mission, whether it’s filing patents, licensing technologies, or guiding early-stage startups. As a way to honor their accomplishments, OTT nominates outstanding faculty innovators to the National Academy of Inventors (NAI), an esteemed organization that recognizes inventors with U.S. patents. In our 40 years of existence, OTT has fostered relationships with faculty members and encouraged academic inventorship. Here, we spoke with several of Emory’s esteemed NAI Fellows and Senior Members about their career as innovators and experiences partnering with OTT. Read More …

No Patent Needed: Commercializing with Copyrights and Open-Source Licenses – Part 1

In the process of commercialization, the word “patent” has become something of a status symbol. Which is fair, considering the basic road to commercialization is to invent, patent, and produce. But what about copyrights and open-source software (OSS) licenses, which don’t involve patents? These different types of intellectual property warrant special consideration during the commercialization process. What is a license? The term “license” comes up quite a bit in the commercialization process. Basically, a license is an agreement between the owner of the intellectual property and the entity that wants to use said intellectual property. The agreement allows the licensee Read More …

The Emory OTT Licensing Internship: Cultivating the Next Generation of Tech Transfer

The OTT licensing internship, according to its coordinator Catherine Murari-Kanti, PhD, is about “setting up a pipeline for future licensing associates and the future of tech transfer by making sure we have excellently trained people who can take the reins over the next few years.” The program, aimed at graduate students both within the Emory community and outside of it, offers interns a look at a fulfilling career outside the lab – one that sits at the exciting intersection of science, business, law, and innovation. What to Expect The program commences in the last week of August, where the students Read More …

4 Emory OTT Success Stories You Might Not Know

Emory’s Office of Technology Transfer has transformed many ideas into products on the market in the last 40 years. You may have even heard of some of our products, like the HIV antiretrovirals emtricitabine and lamivudine, which went on to become brand names like Truvada, Dovato, and Descovy. Or maybe you’ve heard of molnupiravir, one of the world’s first approved oral medications for the treatment of COVID-19. While not all of Emory’s 65+ products to make it to the market have been blockbusters, they all certainly have created positive impact. Here, we’re highlighting a few under-the-radar success stories that demonstrate Read More …

The 2025 Tech Partnership Forum: Technology, Partnering and Faculty Honors

Each year, Emory researchers push the boundaries of innovation, developing groundbreaking technologies with the potential to change the world. When these technologies are patented, licensed, and brought to market, it marks a significant milestone in advancing research and real-world impact. On April 17, 2025, Emory OTT hosted the Tech Partnership Forum: Technology, Partnering & Faculty Honors. Since the event’s inception in 2007, it’s changed names and locations, and it’s grown to host more than 150 people. But even as it’s evolved, our annual event has always highlighted exceptional faculty contributions to innovation and commercialization. It was an especially remarkable year, Read More …

Transforming Ideas into Impact: Linda Kesselring’s Legacy in Emory’s Office of Technology Transfer

  Linda Kesselring is a seasoned operations leader who has dedicated nearly 30 years to Emory University, with almost two decades as the Operations Director in the Emory Office of Technology Transfer (OTT). Throughout her career, she has been a key player in enhancing the office’s strategic direction, focusing on project management, financial oversight, and technology transfer. Linda’s innovative approach has led to significant improvements in operational efficiency and has fostered a culture of excellence within the team. Notably, her efforts have helped position OTT as a leader in the field, enabling impactful collaborations and driving advancements in technology transfer. Read More …

15 Good Minutes: Claudia Morris, MD

Pediatric emergency medicine physician, research director for the Center of Clinical and Translational Research, professor of Pediatrics and Emergency Medicine at the Emory University School of Medicine, and chief investigator for the Pediatric Emergency Care Applied Research Network. These are only a few of the many hats that Claudia Morris, MD, wears as she works to improve the lives of her patients, students, and those impacted by her clinical research. Morris has been involved with clinical and translational research for over 25 years. In her words, it has been “quite a journey.” That said, she didn’t intend to be a Read More …

OTTers Reflect on 40 Years of Creating Impact

Emory’s Office of Technology Transfer (OTT) helps researchers and inventors turn their research into reality, and the people behind the scenes make it possible. OTT staff members are a tight-knit team who work tirelessly to commercialize Emory technologies and maximize their impact. Did you know that we call ourselves OTTers (or “otters”)? Our collective nickname, along with our monthly OTTer Award honoring high-performing licensing associates, build a strong sense of camaraderie and drive us to do our best work. To celebrate the outstanding work of OTT employees over our 40 years, we asked a few current OTTers about their experience Read More …

Celebrating 40 Years of Innovation: The Story of Emory OTT

The passage of the Bayh-Dole Act in 1980, which allowed universities to take ownership of their inventions made with federally funded research, was a pivotal moment for academic innovation. The shift prompted universities nationwide—including Emory University—to establish technology transfer offices to facilitate this newfound process, and by 1985, Emory had created its Office of Technology Transfer (OTT). Over the next four decades, Emory OTT grew into a leader in the field, setting the standard for how universities can transform academic innovation into tangible solutions. As we celebrate 40 years of Emory OTT, let’s take a closer look at its beginnings, Read More …

Biolocity: The Business of Making Science

What’s the real measure of research impact? To quote John Nicosia, the former interim managing director of Biolocity, “A researcher might consider their research to be impactful if they publish their findings in a prominent journal and receive 200 citations on their paper. But imagine the impact if their research was translated into a product that treated 200,000 people.” That’s the goal of Biolocity: to find promising biomedical research in academia and supply those researchers with the resources, support, and tools they need to make their dreams of making an impact in medicine a reality. Overcoming guidance and funding challenges Read More …

From the Director: Emory OTT Celebrates 40 Years of Innovation

Happy New Year, and I hope 2025 brings you joy, happiness, and prosperity. This year marks the 40th anniversary of Emory’s Office of Technology Transfer (OTT), so I’m reflecting on what the world looked like four decades ago. In 1985, Back to the Future was released, and who knew the kind of cultural phenomenon it would become? Michael Jordan was also named NBA’s Rookie of the Year in 1985 (but I think we all knew then that he was something special). Personally, I’d just finished my undergraduate degree at Oregon State University and had begun my research career at the Read More …

Happy Holidays! Love, the Algorithm: How Your Browsing History Affects Your Holiday Shopping

It’s the season of giving, so it’s time to search the vast expanse of online stores to find the perfect gifts! But browser beware: When you visit a website, you leave behind information about yourself. Those websites you visit may use this data to track your online activity and preferences, which can affect how you experience any given website across the internet. Here are a few ways technology impacts your holiday online shopping. Letters to Santa (…Or Searches on Your Browser) Many businesses try to increase their profit by optimizing their user experience, whether their customers shop online or at Read More …

Trademarked traditions: How IP shapes the holiday season

Santa and his elves, Rudolph’s red nose, and the melodies of our favorite holiday songs: Many of us cannot imagine the holiday season without the array of familiar symbols we attach to it. However, behind the joy and nostalgia of these seemingly timeless traditions lies the often-overlooked world of intellectual property (IP) law. While these laws ensure creators receive the recognition they deserve for their work, they also play a surprising role in shaping how we share and celebrate the staples of the holiday season. Protecting holiday icons Take Santa, for example. While the character of Santa Claus, with his Read More …

How To: Build an Effective Start-Up Pitch Deck

A strong pitch deck is a must for any academic entrepreneur aiming to take their research to the next step and launch a start-up. Decks are the foundation of how ideas are communicated in business but translating years of rigorous research and ambitious plans into a concise and digestible presentation requires strategy, clarity, and a deep understanding of your audience in the market. So, how can you create a pitch deck that captures attention and inspires confidence in your start-up? 1. Start with your Elevator Pitch The opening slide of your deck sets the tone for the rest of your Read More …

I’ve Submitted my Invention … Now What?: Or, The First Steps with Emory OTT!

  A faculty member has a great invention. They submit an invention disclosure. What happens next? Emory’s Office of Technology Transfer (OTT) is an Emory researcher’s first stop on the road to commercialization. From the moment a disclosure is submitted, our staff works to ensure a smooth and efficient process for all parties involved. Each invention disclosure is assigned a tech ID number and OTT licensing associate. The licensing associate will then have some initial conversations with the faculty member about their goals for the product or project and the type of funding surrounding their research. From this point on, Read More …